EVERYTHING XIAOMI
Get listed
Side by side

ImmuniWeb vs VAddy

ImmuniWeb logo

ImmuniWeb

6.8#3 in web application security scannersFrom €595 a year
AndroidiOSWebAPI
Visit

VAddy

6.6#6 in web application security scannersFrom ¥19,800 a month
WebAPILinuxmacOS
Visit

What both publish

FactImmuniWebVAddy
ComplianceDiscovery states that it helps address monitoring requirements under regulations and frameworks including GDPR, DORA, NIS 2, HIPAA, ISO 27001, SOC 2 and PCI DSS.Bitforest says it has ISO 27001 and ISO 27017 certifications, and lists Tokyo as its headquarters.
HeadquartersGeneva, SwitzerlandTokyo, Japan
IntegrationsThe maker lists integrations including GitHub Actions, GitLab CI/CD, Azure Pipelines, Jenkins, Asana, Jira, Slack, Splunk, Okta and Microsoft Teams.The maker lists Jenkins, CircleCI, Codeship, Travis CI, Wercker, a Web API, a Ruby client, and a Go API command tool.
SupportDiscovery packages include 24/7 expert assistance through a dedicated support system.The plan page includes free human support and PDF report export.

ImmuniWeb plans

  • ImmuniWeb Neuron — Monthly Scan Subscription€395 a month
  • ImmuniWeb Neuron Mobile — Monthly Scan Subscription€395 a month
  • ImmuniWeb Neuron — Annual Scan Subscription€595 a year
  • ImmuniWeb Neuron Mobile — Annual Scan Subscription€595 a year
  • ImmuniWeb Discovery — ASM package€1,495 a month
  • ImmuniWeb Discovery — Dark Web package€1,495 a month

VAddy plans

  • Professional¥19,800 a month
  • Enterprise¥59,800 a month
  • Advanced¥99,800 a month

Pick ImmuniWeb if…

It may suit organizations that need application or API scans, penetration testing, or ongoing attack-surface monitoring. The no-cost Community Edition is aimed at SMEs, educational institutions, and small municipal governments seeking cybersecurity, privacy, and compliance checks.

Pick VAddy if…

VAddy suits teams that need recurring security scans in a CI workflow, including development and QA teams. Its Advanced plan is described for users seeking an assessment standard aligned with IPA guidance.

Charts they share